Fact sheet: The Biotech Growth Trust PLC

Fund information

Fund name
The Biotech Growth Trust PLC
Fund company manager
Frostrow Capital LLP
Fund type
ITR
Fund manager
Geoffrey C. Hsu
since 19/05/2005
Fund objective
The Biotech Growth Trust PLC seeks capital appreciation through investment in the worldwide biotechnology industry. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).
Benchmark
NASDAQ Biotechnology
Investment style
Growth
Investment method
-

Performance snapshot

Quick stats

1 Year return

36.58 %

1 Year rank in sector

3/4

Sector

IT Biotechnology & Healthcare

Yield
-
Fund size

£ 449.5 m

FE Risk score

202

NAV

870.27

Discount/Premium

+-7.5

Gearing

103

Top in sector

Holdings snapshot

  • North America
    86.8%
  • Continental Europe
    10%
  • UK
    1.9%
  • Not Specified
    0.8%
  • Others
    0.5%
  • North American Equities
    86.8%
  • European Equities
    10%
  • UK Equities
    1.9%
  • International Equities
    1.3%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund15.29 %13.62 %40.73 %63.7 %212.02 %
Sector8.83 %15.19 %41.46 %81.67 %200.88 %
Rank within sector1 / 54 / 53 / 43 / 43 / 4
Quartile th1 st4 th3 rd3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund14.18 %-4.73 %9.14 %44.87 %60.14 %
Sector15.05 %6.22 %12.73 %39.34 %43.24 %
Rank within sector3 / 54 / 43 / 42 / 41 / 4
Quartile th3 rd4 th3 rd2 nd1 st

Risk statistics

Alpha-10.14
Beta1.39
Sharpe0.4
Volatility29.25
Tracking error12.72
Information ratio-0.37
R-Squared0.87

Price movement

52 week high805
52 week low564
Current bid price805
Current offer price814
Current mid price805

Holdings by region

  • 86.8% North America
  • 10% Continental Europe
  • 1.9% UK
  • 0.8% Not Specified
  • 0.5% Others

Holdings by sector

-

Holdings by asset type

  • 86.8% North American Equities
  • 10% European Equities
  • 1.9% UK Equities
  • 1.3% International Equities

Individual holdings

  • 12.3% CELGENE CORP
  • 10.6% BIOGEN INC
  • 9% VERTEX PHARMACEUTICAL
  • 7.4% REGENERON PHARMACEUTICALS INC
  • 6.9% INCYTE CORP
  • 6.8% ALEXION PHARMACEUTICALS INC
  • 4.3% ILLUMINA INC
  • 3.9% AMGEN INC
  • 3% DBV TECHNOLOGIES
  • 3% PUMA BIOTECHNOLOGY INC